The Beauty Health Company (NASDAQ:SKIN – Get Rating) – Stock analysts at Jefferies Financial Group cut their Q2 2022 EPS estimates for Beauty Health in a research note issued to investors on Tuesday, May 10th. Jefferies Financial Group analyst S. Wissink now forecasts that the company will earn ($0.01) per share for the quarter, down from their previous forecast of $0.01. Jefferies Financial Group also issued estimates for Beauty Health’s Q2 2023 earnings at $0.03 EPS and FY2023 earnings at $0.19 EPS.
Beauty Health (NASDAQ:SKIN – Get Rating) last issued its earnings results on Tuesday, May 10th. The company reported ($0.06) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.05). The company had revenue of $75.40 million during the quarter, compared to analyst estimates of $68.15 million. Beauty Health had a negative return on equity of 0.01% and a negative net margin of 117.84%. The business’s revenue for the quarter was up 58.7% on a year-over-year basis.
Shares of SKIN stock opened at $11.94 on Thursday. Beauty Health has a 1-year low of $9.94 and a 1-year high of $30.17. The company has a current ratio of 13.09, a quick ratio of 12.63 and a debt-to-equity ratio of 2.41. The company has a market capitalization of $1.79 billion, a price-to-earnings ratio of -3.51 and a beta of 1.73. The stock’s fifty day simple moving average is $15.41 and its 200-day simple moving average is $18.99.
A number of institutional investors and hedge funds have recently modified their holdings of the stock. BlackRock Inc. increased its stake in Beauty Health by 5.8% during the first quarter. BlackRock Inc. now owns 7,778,389 shares of the company’s stock valued at $131,300,000 after acquiring an additional 423,084 shares during the period. William Blair Investment Management LLC grew its stake in shares of Beauty Health by 232.2% in the 4th quarter. William Blair Investment Management LLC now owns 6,251,906 shares of the company’s stock valued at $151,046,000 after purchasing an additional 4,370,217 shares during the period. Invesco Ltd. grew its stake in shares of Beauty Health by 33.8% in the 4th quarter. Invesco Ltd. now owns 4,612,468 shares of the company’s stock valued at $111,437,000 after purchasing an additional 1,164,268 shares during the period. Marshall Wace LLP bought a new stake in shares of Beauty Health in the 3rd quarter valued at approximately $106,826,000. Finally, Luxor Capital Group LP grew its stake in shares of Beauty Health by 29.7% in the 4th quarter. Luxor Capital Group LP now owns 4,108,912 shares of the company’s stock valued at $99,271,000 after purchasing an additional 941,138 shares during the period. Hedge funds and other institutional investors own 72.01% of the company’s stock.
Beauty Health Company Profile (Get Rating)
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, peel, exfoliate, extract, infuse, and hydrate the skin with proprietary solutions and serums.
- Get a free copy of the StockNews.com research report on Beauty Health (SKIN)
- MarketBeat: Week in Review 5/9 – 5/13
- Is Electronic Arts (NASDAQ: EA) Suddenly A Safe Haven?
- Beyond Meat Stock Value is Improving
- The Travel Sector Is Getting Upgraded
- Carvana Insiders Buy Shares But Maybe You Shouldn’t
Receive News & Ratings for Beauty Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beauty Health and related companies with MarketBeat.com's FREE daily email newsletter.